Estrogen receptor-negative invasive breast cancer: Imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression

Yingbing Wang, Debra M. Ikeda, Balasubramanian Narasimhan, Teri A. Longacre, Richard J. Bleicher, Sunita Pal, Roger J. Jackman, Stefanie S. Jeffrey

Research output: Contribution to journalArticlepeer-review

132 Scopus citations

Abstract

Purpose: To prospectively determine if estrogen receptor (ER)-negative human epidermal growth factor receptor type 2 (HER2)-positive and ER-negative HER2-negative breast cancers have distinguishing clinical and imaging features with use of retrospectively identified patients and tissue samples. Materials and Methods: This HIPAA-compliant study was institutional review board approved. Informed consent was obtained from living patients and waived for deceased patients. Mean patient age at diagnosis was 53 years (range, 31-84 years). Clinical history; histopathologic, mammographic, and breast sonographic findings; and HER2 status as determined with immunohistochemistry or fluorescent in situ hybridization were evaluated in 56 women with ER-negative breast cancer. Imaging appearances and clinicopathologic characteristics were correlated with tumor HER2 status. P < .05 indicated a significant difference. Results: Lesion margins on mammograms (P = .028) and sonograms (P = .023), calcifications on mammograms (P = .003), and clinical cancer stage at diagnosis (P = .029) were significantly associated with HER2 status. In contrast to ER-negative HER2-negative tumors, ER-negative HER2-positive tumors were more likely to have spiculated margins (56% vs 15%), be associated with calcifications (65% vs 21%), and be detected at a higher cancer stage (74% vs 57%). Conclusion: Biologic diversity of cancers may manifest in imaging characteristics, and, conversely, studying the range of imaging features of cancers may help refine current molecular phenotypes.

Original languageEnglish
Pages (from-to)367-375
Number of pages9
JournalRadiology
Volume246
Issue number2
DOIs
StatePublished - Feb 2008

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor/metabolism
  • Breast Neoplasms/classification
  • Calcinosis/classification
  • Female
  • Humans
  • Male
  • Mammography/methods
  • Middle Aged
  • Receptor, ErbB-2/metabolism
  • Reproducibility of Results
  • Sensitivity and Specificity

Fingerprint

Dive into the research topics of 'Estrogen receptor-negative invasive breast cancer: Imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression'. Together they form a unique fingerprint.

Cite this